BAM Logo

ESEAP: Greek EQA Scheme. Part 12 - Viral Markers Screening (In collaboration with EUROREFLAB - Belgium, The Netherlands, Denmark, Finland, Greece and Cyprus)

EPTIS factsheet 275868 | Last revision 2023-05-04 | URL: https://www.eptis.bam.de/pts275868 https://www.eptis.bam.de/pts275868

PT provider
Based in Greece
Language(s) Greek-English
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Human sera, lyophilized HBsAg -
Anti HBc -
Anti HBs -
HCV antibody -
HIV 1/2 -
Anti treponemic antibodies -
HTLV antibody -
Aims of the PT scheme
Target group of participants Clinical Laboratories
Linked to specific legislation / standards
Additional, subsidiary aims validation of testing methods
Number of participants 20
Accredited or otherwise reviewed by a 3rd party

Recognised by TÜV Hellas on the basis of ISO 9001

Operation is commissioned / requested by
Fees and frequency
Participation fee 110 Euro + VAT per analyte per distribution
Regularly operated Yes (trimonthly)
Year of first operation 2017
Contact details of the PT provider
Provider Contact person
47, Alopekis str.
10676 Athens

Phone: +30 2107292403
Fax: +30 2103645392
Web: http://www.eseap.gr http://www.eseap.gr
Dr. Alexander Haliassos
Phone: +30 2107292403
Fax: +30 2103645392
Email: info@eseap.gr info@eseap.gr
If you find any mistakes please contact the responsible EPTIS coordinator in Greece, Ms Vicky Nikou. Ms Vicky Nikou.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5